glp 1 agonist 종류 Comparing Ozempic, Wegovy and Other GLP-1 Drugs Trends in the Development of

doi: 10.1002/jnr.22565 [DOI] [PubMed] [Google Scholar] 69

Online supplemental table 1 provides comprehensive information on reported anomalies, concomitant medications and maternal conditions

In a recent joint statement, FDA and EMA agree that concerns regarding a causal association between incretin-mimetic drugs and pancreatitis or pancreatic cancer are inconsistent with the available evidence [85]

Del Prato S, Barnett AH, Huisman H, et al

71 , 73 Another strength is represented by the retrieval of serious adverse events from multiple sources, that is, public trial repositories, and not only publications

Beyond T2D and obesity, semaglutide was also applied for other indications such as cardiovascular disease, fatty liver, chronic kidney disease, all of which have progressed to Phase 3, expanding the influence of GLP-1RAs into more medical fields